Astaxanthin dosage and evidence
Written by Aaron CuhaReviewed Sep 2026
The short answer
Astaxanthin made male mice live longer once. When the same program tested it again at a different dose, it did nothing. In females, with all three labs added together, it was linked to shorter lives.
Evidence grade for Astaxanthin: Animal or lab only. The rule: only animal or lab studies on this page. No study in people yet. The sum on this page: 2 animal studies, no human study. A grade counts how much has been done to people, not whether it works.
- People given it
- 0
- Human studies
- 0
- Found nothing
- 0
Dose
No human dose established
No published study on this page has given this compound to people and reported a result.
2 animal studies, no human study
5 effects reported, 4 unwanted, 1 wanted, by people using it, not a trial
Goal pages: Ageing and longevity
In plain English
In plain English, from Aaron
This is how I would explain it to a friend. The evidence, with the numbers, is further down the page.
This is the red orange pigment from a tiny water plant. It is what makes salmon and flamingos pink. It is sold as a supplement. It made male mice live longer once, then did nothing when the same program tried again.
What people take it for
- Living longer, off that one mouse result.
- Protecting cells from damage.
- Skin and eye health.
What studies in people showed
No study in people has looked at lifespan or healthy years. Its human studies are about blood markers and short term results. In mice, the 2024 round of the government program found males lived longer when started at 12 months old. The longest lived males gained 6 percent, which did not pass the formal test. In 2026 the same program tried again at a different dose and a later start. It did nothing. In females, with all three labs added up, it was linked to shorter lives. A closer look found one lab had untreated females that lived unusually long. Leaving that lab out removed the harm for this one. Two authors of the win ran the company that supplied it, and they said so.
What people report
Reports, not study results
The good
- We have not collected user reports on this one yet.
- In studies it was well tolerated at supplement doses.
The bad
- At higher intakes, the main thing people notice is a change in skin colour.
- It needs fat in the meal or your body barely absorbs it.
- The same program tested it twice and got opposite answers.
- In female mice, pooled across labs, it was linked to shorter lives.
Where these come from: The tolerance and absorption notes come from the human marker studies on this page. The lifespan numbers come from the two mouse rounds here. No user reports have been collected.
My bottom line
One win, one miss, same program, and a supplier sitting on the winning paper. For ageing, nobody knows.
An opinion, not a finding. I am a coach, not a doctor.
What it has been measured to do
Animal and lab work, not yet tested in people
Real results, but from animals or cells, not people. What works in a mouse often does not work the same way in a person. Nobody can patent this, so nobody would ever earn back the cost of a study in people. That is usually why there is none. The record on this one is set out below.
- Living longer2 animal or lab studies
35 of the 36 indexed goals have no study of any kind behind Astaxanthin
No study in people, animals or cells on this page reports a result for these. That does not prove Astaxanthin does nothing for them. It does mean anything you have heard about Astaxanthin and one of these did not come from a study cited here.
Show full evidence
What is Astaxanthin?
Astaxanthin made male mice live longer once. When the same program tested it again at a different dose, it did nothing. In females, with all three labs added together, it was linked to shorter lives.
Astaxanthin is the clearest example on this site of one idea. A lifespan result belongs to a dose, not to a compound.
It is widely sold, and many studies in people look at blood markers and short-term results. None of them looked at lifespan or healthy years.
In mice, the 2024 round of the government testing program found it helped males live longer. The longest-lived males lived 6 percent longer. That rise did not pass the formal test for longest lifespan. Still, it was a real, published win.
In 2026 the same program tested it again, at a different dose and a later starting age. It did nothing. In females, with all three labs added together, it was linked to shorter lives. Then a closer look found one lab had untreated females that lived unusually long. Leaving that lab out removed the harm for astaxanthin. The harm stayed for two other compounds.
So: same compound, same program, same mice. A win once, nothing the second time, and a harm signal in females that showed up and then partly faded. One more thing to know. In the 2024 paper, two authors run the company that supplied the astaxanthin.
How does Astaxanthin work?
Astaxanthin is a red-orange pigment made by a tiny water plant, the microalga Haematococcus pluvialis. It is what makes salmon and flamingos pink. Its shape lets it stretch right across the thin skin around each cell, instead of sitting inside it like beta-carotene does. That is the basis of the claim that it guards cells better. It mops up reactive oxygen and free radicals. Unlike some pigments of its kind, the body does not turn it into vitamin A. One warning: a plain antioxidant story fits badly with lifespan research. Taking antioxidants has failed again and again to extend life, and sometimes shortened it.
What have studies in people found about Astaxanthin?
It is widely sold, and many studies in people look at blood markers and short-term results. None look at lifespan or healthy years.
- No study in people has looked at lifespan, healthy years or any ageing measure.
- It is well tolerated at supplement doses. At higher amounts, the main thing people notice is a change in skin colour.
- It is absorbed much better when taken with fat in a meal.
- The lifespan evidence is two rounds of mouse tests from the same program, and they disagree.
What this does not tell you: The two mouse results are the whole ageing case, and they contradict each other. That is the most useful thing to know. The win came from a paper where two authors ran the supplier, and they said so. The same program tested it again at a different dose and starting age, and found nothing. A harm signal in females showed up when all labs were added together, then partly faded when each lab was checked. None of that is a scandal. It is what careful testing looks like. The honest answer on astaxanthin and lifespan is that nobody knows.
The state of the research
In 2026 the program did something rare and useful. It tested some compounds again that it had already found to make mice live longer. This time it used different doses or started later in life. Astaxanthin, mitoglitazone and meclizine all did nothing the second time. In females, with all three labs added together, astaxanthin, late-start mitoglitazone and pioglitazone were linked to shorter lives. Then the team looked lab by lab. One lab had untreated females that lived unusually long. With that lab left out, the harm showed up only for mitoglitazone and pioglitazone. The authors' own view is that timing and dose matter a lot. One result from one lab or one round of testing should be read with care.
Astaxanthin is the one to point at when someone says a supplement makes mice live longer. It did, once. In males, at one dose, from one starting age, in a study where two authors ran the company that supplied it. The same program tested it again and found nothing. That is not a story about fraud or a bad supplement. It is a story about how fragile a single lifespan result is. It is also why the retest round was the most valuable thing this program published in years.
The Interventions Testing Program is the US government's mouse testing program, run by the National Institute on Aging. It runs every test at three separate labs at once. It uses mice bred to be genetically mixed, so a result cannot come from one odd strain. It tests males and females. Its groups are big enough to spot about a 10 percent change in lifespan. It publishes its failures next to its wins. Nothing else in ageing research does all of that. So its results count for more than one lab's result. And when it fails to repeat a result, that matters just as much as a win.
The evidence, in charts
Fig. 1a · how many people
0people have taken this in any study cited here
0 people · 0 studies in people
What this page cites instead is 2 animal studies. None of them gave the compound to a person.
Counted from the list of sources on this page. We draw this chart only when a study in people is cited. An empty one is the answer, not a gap in the page.
Fig. 1b · evidence mix
None of the 2 sources here are studies in people.
- Animal study · done in animals2100%
Counted from the list of sources on this page. It counts only what we cite, so there may be more studies out there. A review counts once, however many studies it sums up.
Fig. 2 · evidence over time
Sources here come from just two years, 2024 and 2026.
Too few different years on this page to draw a timeline.
Fig. 3 · legal status at a glance
US
Not approved
UK
Not approved
AU
Not approved
CA
Not approved
Not approved in any of the four countries shown. This is what the law says, not a verdict on the science. See Legal status below for the full text and any notes.
Fig. 4 · how much does what
Nobody has tested different amounts in people
This chart would show how the effect changes as the amount goes up. For this compound, nobody has measured that in people. So we leave it empty. We will not borrow an animal chart and pretend it works the same in people.
Fig. 5 · what the molecule is
- Kind of compound
- Supplement
- Molecule weight
- 596.8 Da. A carotenoid, not a peptide.
- Half-life
- About 17.5 hoursMedium, 6 to 24 hours
- Chain length
- None on file
Half-life as stated on file: Roughly 15 to 20 hours in humans, with absorption substantially improved by dietary fat.
No amino acid sequence is on file for Astaxanthin, which is expected: a supplement is not built from amino acids.
The studies we cite
- Animal study2024Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002, dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not
In mice, it helped males live longer in this round. Treatment started at 12 months old. The longest-lived males lived 6 percent longer, but that did not pass the formal test. Females on it weighed less late in life, but did not live longer. Two authors run the company that supplied the astaxanthin, and they said so.
The positive. Astaxanthin extended lifespan in male mice, started at 12 months of age. The 90th percentile lifespan was extended in absolute value by 6 percent in males, though not significantly by the Wang-Allison test. Late-life weights were lower in females fed astaxanthin without a significant lifespan effect in them. Disclosed conflict: two authors run the company that supplies the astaxanthin used in the study.
- Animal study2026Astaxanthin, meclizine, mitoglitazone, pioglitazone, alpha-ketoglutarate, mifepristone, methotrexate, and atorvastatin-telmisartan do not increase lifespan
In mice, the retest found nothing. At a different dose or a later starting age, it did not help lifespan. In females, with all three labs added together, it was linked to shorter lives. But one lab had untreated females that lived unusually long. With that lab left out, the harm held only for two other drugs, not astaxanthin. The authors say timing and dose matter a lot.
The retest. Astaxanthin showed no lifespan benefit when administered at a different dose or starting at a later age. In females, pooling all three sites, astaxanthin was associated with significantly reduced lifespan; site-specific reanalysis excluding one site with unusually long-lived control females left a negative effect only for mitoglitazone and pioglitazone. The authors conclude that timing and dosage are critical variables.
Common questions
Has Astaxanthin been tested in people?
Not in any study cited here. Astaxanthin made male mice live longer once. When the same program tested it again at a different dose, it did nothing. In females, with all three labs added together, it was linked to shorter lives.
What is the Astaxanthin dosage?
No human dose established. No published study on this page has given this compound to people and reported a result. 2 animal studies, no human study
Is Astaxanthin FDA-approved?
Sold as a dietary supplement. Not an approved drug and not approved to prevent or treat anything.
Does astaxanthin extend lifespan?
It did in male mice, in one round, at one dose. The same program tested it again at a different dose and a later starting age, and it did nothing. There is no lifespan data in people. The honest answer is that nobody knows.
Was the positive result compromised?
The link was disclosed, not hidden. Two authors of that paper run the company that supplied the astaxanthin. That does not throw the result out. But it is a reason to give the independent retest, which found nothing, at least as much weight as the first result.
Is it harmful in females?
When all three labs were added together, it was linked to shorter lives in female mice. Then one lab turned out to have untreated females that lived unusually long. Leaving that lab out removed the effect for astaxanthin, but not for two other compounds. So the signal is uncertain, not proven. It is a reason for caution, not alarm.
Is it worth taking at all?
For ageing, nothing supports it. It is well tolerated. It needs fat in the meal to be absorbed. Its studies in people are about blood markers and short-term results, not lifespan.
Latest reading on Astaxanthin
Blog posts about Astaxanthin, newest first.